Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RUCAPARIB vs RUFINAMIDE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RUCAPARIB vs RUFINAMIDE: Safety Overview

Metric RUCAPARIB RUFINAMIDE
Total FAERS Reports 434 871
Deaths Reported 50 27
Death Rate 11.5% 3.1%
Hospitalizations 310 229
Average Patient Age 64.3 yrs 16.9 yrs
% Female Patients 69.5% 50.2%
FDA Approval Date N/A Apr 15, 2025
Manufacturer N/A Aurobindo Pharma Limited
Route N/A ORAL
Marketing Status N/A Discontinued